Monodelphis domestica (gray short-tailed opossum): 654273
Help
Entry
654273 CDS
T01031
Symbol
CASP3
Name
(RefSeq) caspase 3
KO
K02187
caspase 3 [EC:
3.4.22.56
]
Organism
mdo
Monodelphis domestica (gray short-tailed opossum)
Pathway
mdo01524
Platinum drug resistance
mdo04010
MAPK signaling pathway
mdo04115
p53 signaling pathway
mdo04148
Efferocytosis
mdo04210
Apoptosis
mdo04215
Apoptosis - multiple species
mdo04623
Cytosolic DNA-sensing pathway
mdo04650
Natural killer cell mediated cytotoxicity
mdo04657
IL-17 signaling pathway
mdo04668
TNF signaling pathway
mdo04726
Serotonergic synapse
mdo04932
Non-alcoholic fatty liver disease
mdo04933
AGE-RAGE signaling pathway in diabetic complications
mdo04936
Alcoholic liver disease
mdo05010
Alzheimer disease
mdo05012
Parkinson disease
mdo05014
Amyotrophic lateral sclerosis
mdo05016
Huntington disease
mdo05020
Prion disease
mdo05022
Pathways of neurodegeneration - multiple diseases
mdo05132
Salmonella infection
mdo05133
Pertussis
mdo05134
Legionellosis
mdo05145
Toxoplasmosis
mdo05146
Amoebiasis
mdo05152
Tuberculosis
mdo05160
Hepatitis C
mdo05161
Hepatitis B
mdo05162
Measles
mdo05163
Human cytomegalovirus infection
mdo05164
Influenza A
mdo05165
Human papillomavirus infection
mdo05167
Kaposi sarcoma-associated herpesvirus infection
mdo05168
Herpes simplex virus 1 infection
mdo05169
Epstein-Barr virus infection
mdo05170
Human immunodeficiency virus 1 infection
mdo05200
Pathways in cancer
mdo05203
Viral carcinogenesis
mdo05205
Proteoglycans in cancer
mdo05206
MicroRNAs in cancer
mdo05210
Colorectal cancer
mdo05222
Small cell lung cancer
mdo05416
Viral myocarditis
mdo05417
Lipid and atherosclerosis
Brite
KEGG Orthology (KO) [BR:
mdo00001
]
09130 Environmental Information Processing
09132 Signal transduction
04010 MAPK signaling pathway
654273 (CASP3)
04668 TNF signaling pathway
654273 (CASP3)
09140 Cellular Processes
09141 Transport and catabolism
04148 Efferocytosis
654273 (CASP3)
09143 Cell growth and death
04210 Apoptosis
654273 (CASP3)
04215 Apoptosis - multiple species
654273 (CASP3)
04115 p53 signaling pathway
654273 (CASP3)
09150 Organismal Systems
09151 Immune system
04623 Cytosolic DNA-sensing pathway
654273 (CASP3)
04650 Natural killer cell mediated cytotoxicity
654273 (CASP3)
04657 IL-17 signaling pathway
654273 (CASP3)
09156 Nervous system
04726 Serotonergic synapse
654273 (CASP3)
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
654273 (CASP3)
05206 MicroRNAs in cancer
654273 (CASP3)
05205 Proteoglycans in cancer
654273 (CASP3)
05203 Viral carcinogenesis
654273 (CASP3)
09162 Cancer: specific types
05210 Colorectal cancer
654273 (CASP3)
05222 Small cell lung cancer
654273 (CASP3)
09172 Infectious disease: viral
05170 Human immunodeficiency virus 1 infection
654273 (CASP3)
05161 Hepatitis B
654273 (CASP3)
05160 Hepatitis C
654273 (CASP3)
05164 Influenza A
654273 (CASP3)
05162 Measles
654273 (CASP3)
05168 Herpes simplex virus 1 infection
654273 (CASP3)
05163 Human cytomegalovirus infection
654273 (CASP3)
05167 Kaposi sarcoma-associated herpesvirus infection
654273 (CASP3)
05169 Epstein-Barr virus infection
654273 (CASP3)
05165 Human papillomavirus infection
654273 (CASP3)
09171 Infectious disease: bacterial
05132 Salmonella infection
654273 (CASP3)
05133 Pertussis
654273 (CASP3)
05134 Legionellosis
654273 (CASP3)
05152 Tuberculosis
654273 (CASP3)
09174 Infectious disease: parasitic
05146 Amoebiasis
654273 (CASP3)
05145 Toxoplasmosis
654273 (CASP3)
09164 Neurodegenerative disease
05010 Alzheimer disease
654273 (CASP3)
05012 Parkinson disease
654273 (CASP3)
05014 Amyotrophic lateral sclerosis
654273 (CASP3)
05016 Huntington disease
654273 (CASP3)
05020 Prion disease
654273 (CASP3)
05022 Pathways of neurodegeneration - multiple diseases
654273 (CASP3)
09166 Cardiovascular disease
05417 Lipid and atherosclerosis
654273 (CASP3)
05416 Viral myocarditis
654273 (CASP3)
09167 Endocrine and metabolic disease
04936 Alcoholic liver disease
654273 (CASP3)
04932 Non-alcoholic fatty liver disease
654273 (CASP3)
04933 AGE-RAGE signaling pathway in diabetic complications
654273 (CASP3)
09176 Drug resistance: antineoplastic
01524 Platinum drug resistance
654273 (CASP3)
09180 Brite Hierarchies
09181 Protein families: metabolism
01002 Peptidases and inhibitors [BR:
mdo01002
]
654273 (CASP3)
Enzymes [BR:
mdo01000
]
3. Hydrolases
3.4 Acting on peptide bonds (peptidases)
3.4.22 Cysteine endopeptidases
3.4.22.56 caspase-3
654273 (CASP3)
Peptidases and inhibitors [BR:
mdo01002
]
Cysteine peptidases
Family C14: caspase family
654273 (CASP3)
BRITE hierarchy
SSDB
Ortholog
Paralog
Gene cluster
GFIT
Motif
Pfam:
Peptidase_C14
Motif
Other DBs
NCBI-GeneID:
654273
NCBI-ProteinID:
NP_001033059
Ensembl:
ENSMODG00000004502
UniProt:
Q2V579
LinkDB
All DBs
Position
5:80667744..80691452
Genome browser
AA seq
276 aa
AA seq
DB search
MEDTGTTVDAKSTKNSGVKLFHGSKSVESGLSSDSYKMDYPEMGLCIIINNKNFHPNTGM
SFRSGTDVDAASLSDTFRSLKYEVRIKNDLTCNEITELLNSVSKEDHSQRSSFICVILSH
GEEGVIFGTDRSVELKRLTCFFRGDKCRSLTGKPKLFIIQACRGTELDCGVETDSGTDED
IACQKIPVEADFLYAYSTAPGYYSWRNSKDGSWFIQALCAVLKQHAHKLEIMQILTRVNR
KVATEFESYSLDISFHAKKQVPCIMSMLTKELYFSH
NT seq
831 nt
NT seq
+upstream
nt +downstream
nt
atggaagacactggaactacagtagatgcaaaatccaccaaaaattcaggagtaaaactc
ttccatggtagcaagtcagtggaatctggactgtcatcagacagctataaaatggattat
ccagaaatggggttatgtataataatcaataataagaattttcacccaaacactggtatg
tcatttcgttctggtacagatgttgatgcagcaagcctcagtgatacattcaggagctta
aaatatgaagtcaggattaaaaatgatctgacatgtaatgaaataactgagttactaaac
agtgtttccaaagaagatcacagccaaagaagcagttttatttgtgtgattctaagtcat
ggtgaagaaggagtcatctttggcacagacagatctgttgaactaaaaagattaacgtgt
ttctttagaggagataagtgtagaagccttacaggaaaacccaagctttttattattcag
gcatgtcgaggcacagagttggattgtggtgttgagacagacagtggtacagatgaagat
atagcatgccagaaaatacctgttgaagcagacttcttatatgcatattctacagcccct
ggctactattcctggagaaattcaaaggacggttcgtggtttatccaggcactttgtgct
gtgctgaaacagcatgctcacaagcttgagattatgcaaatccttacccgagtcaatcgg
aaggtggccacagagtttgaatcttattctttagacatttccttccatgcaaagaagcag
gtgccatgtattatgtccatgcttaccaaggaactgtatttttcccattag
DBGET
integrated database retrieval system
